OCUL
Price
$12.69
Change
+$0.44 (+3.59%)
Updated
Sep 24, 12:18 PM (EDT)
Capitalization
2.13B
47 days until earnings call
PRTA
Price
$8.67
Change
+$0.36 (+4.33%)
Updated
Sep 24, 12:23 PM (EDT)
Capitalization
447.33M
36 days until earnings call
Interact to see
Advertisement

OCUL vs PRTA

Header iconOCUL vs PRTA Comparison
Open Charts OCUL vs PRTABanner chart's image
Ocular Therapeutix
Price$12.69
Change+$0.44 (+3.59%)
Volume$1.27K
Capitalization2.13B
Prothena
Price$8.67
Change+$0.36 (+4.33%)
Volume$200
Capitalization447.33M
OCUL vs PRTA Comparison Chart in %
Loading...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OCUL vs. PRTA commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCUL is a Hold and PRTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (OCUL: $12.25 vs. PRTA: $8.31)
Brand notoriety: OCUL and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCUL: 92% vs. PRTA: 43%
Market capitalization -- OCUL: $2.13B vs. PRTA: $447.33M
OCUL [@Biotechnology] is valued at $2.13B. PRTA’s [@Biotechnology] market capitalization is $447.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCUL’s FA Score shows that 0 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • OCUL’s FA Score: 0 green, 5 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, OCUL is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCUL’s TA Score shows that 4 TA indicator(s) are bullish while PRTA’s TA Score has 3 bullish TA indicator(s).

  • OCUL’s TA Score: 4 bullish, 5 bearish.
  • PRTA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both OCUL and PRTA are a bad buy in the short-term.

Price Growth

OCUL (@Biotechnology) experienced а -1.49% price change this week, while PRTA (@Biotechnology) price change was +1.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.34%. For the same industry, the average monthly price growth was +10.13%, and the average quarterly price growth was +53.93%.

Reported Earning Dates

OCUL is expected to report earnings on Nov 10, 2025.

PRTA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+4.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($2.13B) has a higher market cap than PRTA($447M). OCUL YTD gains are higher at: 43.443 vs. PRTA (-40.000). OCUL has higher annual earnings (EBITDA): -200.5M vs. PRTA (-248.1M). OCUL has more cash in the bank: 391M vs. PRTA (371M). PRTA has less debt than OCUL: PRTA (9.78M) vs OCUL (76.9M). OCUL has higher revenues than PRTA: OCUL (56.7M) vs PRTA (10.3M).
OCULPRTAOCUL / PRTA
Capitalization2.13B447M477%
EBITDA-200.5M-248.1M81%
Gain YTD43.443-40.000-109%
P/E RatioN/AN/A-
Revenue56.7M10.3M550%
Total Cash391M371M105%
Total Debt76.9M9.78M786%
FUNDAMENTALS RATINGS
OCUL vs PRTA: Fundamental Ratings
OCUL
PRTA
OUTLOOK RATING
1..100
8362
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
55
Fair valued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
4163
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OCUL's Valuation (52) in the Pharmaceuticals Other industry is in the same range as PRTA (55) in the Biotechnology industry. This means that OCUL’s stock grew similarly to PRTA’s over the last 12 months.

OCUL's Profit vs Risk Rating (84) in the Pharmaceuticals Other industry is in the same range as PRTA (100) in the Biotechnology industry. This means that OCUL’s stock grew similarly to PRTA’s over the last 12 months.

OCUL's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as PRTA (98) in the Biotechnology industry. This means that OCUL’s stock grew similarly to PRTA’s over the last 12 months.

OCUL's Price Growth Rating (41) in the Pharmaceuticals Other industry is in the same range as PRTA (63) in the Biotechnology industry. This means that OCUL’s stock grew similarly to PRTA’s over the last 12 months.

PRTA's P/E Growth Rating (94) in the Biotechnology industry is in the same range as OCUL (100) in the Pharmaceuticals Other industry. This means that PRTA’s stock grew similarly to OCUL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OCULPRTA
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGIUX15.800.14
+0.89%
Virtus Duff & Phelps Global Infras I
JSEAX22.22-0.02
-0.09%
JPMorgan International Equity A
RSIRX14.63-0.02
-0.14%
Victory RS International R6
AEPIX27.92-0.05
-0.18%
Allspring Managed Acct Corebuilder EPI
IBLLX36.08-0.12
-0.33%
Transamerica Multi-Managed Balanced C

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+0.41%
EYPT - OCUL
65%
Loosely correlated
+0.22%
NRIX - OCUL
56%
Loosely correlated
-2.25%
IDYA - OCUL
56%
Loosely correlated
+0.04%
CRNX - OCUL
55%
Loosely correlated
+6.35%
IMVT - OCUL
55%
Loosely correlated
-4.43%
More

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with RCKT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
+0.24%
RCKT - PRTA
51%
Loosely correlated
-2.52%
SVRA - PRTA
45%
Loosely correlated
-0.29%
DNLI - PRTA
40%
Loosely correlated
-2.03%
NUVB - PRTA
35%
Loosely correlated
-1.53%
OCUL - PRTA
35%
Loosely correlated
+0.41%
More